about
Influence of body mass index on the association of weight changes with mortality in hemodialysis patientsThe relationship between the physician and pharmaceutical industry: background ethics and regulation proposalsForearm bone mass predicts mortality in chronic hemodialysis patients.Criteria for calcimimetic agent in the treatment of more severe secondary hyperparathyroidism.COSMOS: the dialysis scenario of CKD-MBD in Europe.Ultrasonographic evaluation of parathyroid hyperplasia in dialysis patients.Use of phosphate-binding agents is associated with a lower risk of mortalitySpontaneous inflammation-induced remission of parathyroid tumour in secondary hyperparathyroidismChelation of aluminium by combining DFO and L1 in ratsSpontaneous remission of hyperparathyroidismDialysis patients: vulnerable group of patientsBone mineral densitometry in patients on hemodialysis: difference between genders and what to measureThe impact of education and cooking methods on serum phosphate levels in patients on hemodialysis: 1-year study
P50
Q37212390-FC64BE43-D9D5-47C4-80F5-D2073FCD9062Q37307255-908ADD5C-A412-45DA-9D36-E625646530D7Q39552433-20B0B819-F88F-4186-B8A0-E0035FC68423Q43514462-72F674DD-B7FE-4EA3-9E91-8B0B791BC57DQ43939289-2BF99B2E-3AC5-4570-998B-8DD4ADDF5AAEQ55398376-3472923D-3138-4A3F-8989-7CD2B6CA292BQ58946500-F0581381-0122-49AC-AC7B-99575583CE32Q67922576-751713F6-ABD3-4F88-AF26-64AC0BEBBF56Q74106519-906BB8F7-7431-48AA-BD87-5F949AECC921Q81937974-D77D6250-C73E-4357-850F-1A25D0E6A725Q82244769-05732FE5-5E4F-449C-A238-5B1296F641F5Q84008837-AF45D2A5-D7D3-45DF-B693-974F874961CBQ88134697-9E47F0B7-C8AB-452A-AAC4-E2D43FD72A95
P50
description
researcher ORCID ID = 0000-0002-2380-869X
@en
name
Drasko Pavlovic
@ast
Drasko Pavlovic
@en
Drasko Pavlovic
@es
Drasko Pavlovic
@nl
type
label
Drasko Pavlovic
@ast
Drasko Pavlovic
@en
Drasko Pavlovic
@es
Drasko Pavlovic
@nl
prefLabel
Drasko Pavlovic
@ast
Drasko Pavlovic
@en
Drasko Pavlovic
@es
Drasko Pavlovic
@nl
P1153
56249403500
P31
P496
0000-0002-2380-869X